Merrimack Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Business combination disclosure

Registration of securities for employees

Registration of securities for employees

Ownership Filter

BlackRock Finance, Inc.

ADAR1 Partners, LP

BlackRock Finance, Inc.

Newtyn Management, LLC

News Filter

Announces Stockholder Approval of Plan of Dissolution and Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

Announces Notification of Plan to Voluntary Delist Comon Stock

Receives $225 Million Milestone Payment From Ipsen Special Meeting of Stockholders to Approve Plan of Dissolution Scheduled for Friday, May 10, 2024 at 10:00 a.m. Eastern Standard Time

Reports Full Year 2023 Financial Results

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC